This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
NEW YORK (
CHANGE IN RATINGSAmerican Eagle(AEO - Get Report) upgraded at Sterne Agee to Buy. $27 price target. Estimates also boosted, as new management initiatives should drive growth.
Advanced Micro(AMD) upgraded at Goldman from Sell to Neutral, Goldman Sachs said. Valuation call, as the stock is down 49% over the past year. $3.50 price target.
Amgen(AMGN - Get Report) upgraded at UBS from Neutral to Buy, UBS said. $96 price target. Expect better near-term clinical data.
Ariad Pharmaceuticals(ARIA) upgraded at BofA/Merrill from Neutral to Buy, Bank of America/Merrill Lynch said. $26 price target. Expect continued strong clinical data in the near term.
Biogen Idec(BIIB) downgraded at UBS from Buy to Neutral, UBS said. $156 price target. Valuation call, as the stock is up 56% from the last upgrade.
Bemis(BMS) rated new Neutral at JPMorgan. $37 price target. Lagging fundamentals balance cash generation story.
Brocade Communications Systems(BRCD) upgraded to buy at TheStreet Ratings.
Colony Financial(CLNY) downgraded to hold at TheStreet Ratings.
Celgene(CELG) downgraded at UBS from Buy to Neutral, UBS said. $80 price target. Valuation call, as the stock is up 27% since Revlimid was not approved in the EU.
Cliffs Natural(CLF) downgraded at Goldman from Buy to Neutral, Goldman Sachs said. $39 price target. Estimates also cut, given lower expected iron ore prices and rising costs.
Carpenter Technology(CRS) upgraded at JPMorgan to Overweight from Neutral, JPMorgan said. $70 price target. Sustainable growth in materials.
Dover(DOV) upgraded at JP Morgan from Underweight to Neutral, JP Morgan said. Valuation call.
Amdocs(DOX) downgraded at Jefferies to Hold from Buy, Jefferies said. $35 price target. Full valuation.
Exelon(EXC) downgraded at Citigroup from Neutral to Sell, Citigroup said. $31 price target. Estimates also cut, given higher expected costs.
Fifth Third Bancorp(FITB) downgraded at Oppenheimer to Perform from Outperform, Oppenheimer said. Catalyst achieved.
Fulton Financial(FULT) upgraded at Sterne Agee to Buy from Hold, Sterne Agee said. $11.50 price target. Attractive valuation.
Hubbell(HUB.B) downgraded at JP Morgan from Overweight to Neutral, JP Morgan said. Stock is already factoring in a late-stage economic recovery.
International Paper(IP) downgraded at Deutsche from Buy to Hold, Deutsche Bank said. $39 price target. Stock is already pricing in a potential price hike, which may not yet materialize.